RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Radiation Injuries
Accession: DOID:9000111
browse the term
Definition: Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES.
Synonyms: exact_synonym: Radiation Injury; Radiation Sickness; Radiation Sicknesses; Radiation Syndrome; Radiation Syndromes; Radiation-induced nausea and vomiting
primary_id: MESH:D011832
xref: EFO:0006912 ; EFO:0009566
GViewer not supported for the selected species.
G
BDNF
brain derived neurotrophic factor
treatment
ISO
RGD
PMID:24333433
RGD:10059359
NCBI chr 1:37,386,825...37,451,380
Ensembl chr 1:37,449,593...37,450,336
G
CSF2
colony stimulating factor 2
ISO
mRNA:increased expression:bone marrow,spleen:
RGD
PMID:7662961
RGD:10449513
NCBI chr23:34,906,987...34,911,252
Ensembl chr23:34,908,911...34,911,140
G
GPX3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:20105084
RGD:401827914
NCBI chr23:53,576,950...53,585,321
G
HIF1A
hypoxia inducible factor 1 subunit alpha
treatment
ISO
RGD
PMID:17340073
RGD:8695920
NCBI chr24:38,873,830...38,927,657
Ensembl chr24:38,873,861...38,928,288
G
IL1A
interleukin 1 alpha
ISO
RGD
PMID:7938676
RGD:7794763
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16540396 PMID:21945096
NCBI chr13:87,284,537...87,297,998
Ensembl chr13:87,280,686...87,297,974
G
TGFBR2
transforming growth factor beta receptor 2
ISO
RGD
PMID:12957270
RGD:1601599
NCBI chr15:75,112,903...75,200,263
Ensembl chr15:75,112,561...75,197,711
G
ABCB1
ATP binding cassette subfamily B member 1
susceptibility
ISO
DNA:missense mutation:cds:p.G671V (human)
RGD
PMID:16330681
RGD:11041175
NCBI chr21:61,211,044...61,430,691
Ensembl chr21:61,322,748...61,529,274
G
ACVR2B
activin A receptor type 2B
treatment
ISO
human construct in mouse model
RGD
PMID:30765322
RGD:329849112
NCBI chr15:923,222...962,438
G
CAPN2
calpain 2
treatment
ISO
RGD
PMID:25634181
RGD:13792617
NCBI chr25:5,845,873...5,905,464
Ensembl chr25:5,846,298...5,905,402
G
ERCC2
ERCC excision repair 2, TFIIH core complex helicase subunit
ISO
associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human)
RGD
PMID:24284041
RGD:11252190
NCBI chr 6:38,804,296...38,823,229
Ensembl chr 6:38,801,423...38,823,073
G
ACACB
acetyl-CoA carboxylase beta
ISO
mRNA, protein:increased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr11:104,325,250...104,488,567
Ensembl chr11:104,349,573...104,488,003
G
AGT
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33676887
NCBI chr25:67,964,840...67,977,006
Ensembl chr25:67,962,401...67,973,324
G
BCHE
butyrylcholinesterase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26145887
NCBI chr15:23,708,121...23,778,027
Ensembl chr15:23,708,155...23,778,286
G
BMP2
bone morphogenetic protein 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29800642
NCBI chr 2:31,349,394...31,361,227
Ensembl chr 2:31,348,808...31,360,901
G
CAT
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35792220
NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
G
CCL2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
G
CPT1A
carnitine palmitoyltransferase 1A
ISO
mRNA, protein:decreased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr 1:5,704,275...5,784,077
Ensembl chr 1:5,730,853...5,784,337
G
CSF1
colony stimulating factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32068018
NCBI chr20:23,615,107...23,635,399
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
G
FASLG
Fas ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34713381
NCBI chr25:56,488,572...56,496,469
Ensembl chr25:56,489,417...56,496,251
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
DNA:hypermethylation:promoter
RGD
PMID:35462195
RGD:329951017
NCBI chr 5:39,487,304...39,900,238
Ensembl chr 5:39,487,418...39,725,747
G
HBEGF
heparin binding EGF like growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29305325
NCBI chr23:42,981,640...42,995,116
Ensembl chr23:42,981,640...42,994,995
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32068018
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
KCNN2
potassium calcium-activated channel subfamily N member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:32909839 PMID:33887967
NCBI chr23:17,595,661...17,735,675
Ensembl chr23:17,598,177...17,735,669
G
METTL14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34648132
NCBI chr 7:66,169,080...66,195,324
Ensembl chr 7:66,168,855...66,194,121
G
MLYCD
malonyl-CoA decarboxylase
ISO
protein:increased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr 5:69,312,978...69,329,346
Ensembl chr 5:69,313,062...69,329,102
G
NOS3
nitric oxide synthase 3
treatment
ISO
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human)
RGD
PMID:26345518
RGD:11533645
NCBI chr21:119,174,829...119,196,840
G
NPPB
natriuretic peptide B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr20:119,930,931...119,933,391
Ensembl chr20:119,932,021...119,933,197
G
NRG1
neuregulin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29305325
NCBI chr 8:29,745,984...30,862,140
Ensembl chr 8:30,635,803...30,856,487
G
PRKAA2
protein kinase AMP-activated catalytic subunit alpha 2
ISO
protein:decreased expression:serum, heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr20:76,258,063...76,319,512
Ensembl chr20:76,259,763...76,319,430
G
RAC1
Rac family small GTPase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28710503
NCBI chr28:15,583,609...15,610,753
Ensembl chr28:15,583,516...15,610,328
G
RARG
retinoic acid receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26237429
NCBI chr11:49,319,104...49,340,725
Ensembl chr11:49,319,839...49,328,656
G
RNF10
ring finger protein 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36740146
NCBI chr11:115,888,359...115,930,790
Ensembl chr11:115,893,457...115,930,848
G
SIRT6
sirtuin 6
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34713381
NCBI chr 6:3,924,230...3,932,583
Ensembl chr 6:3,924,230...3,932,590
G
TLR2
toll like receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987 PMID:32068018
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30009776 PMID:34713381
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
G
AGTR1
angiotensin II receptor type 1
ISO
RGD
PMID:14982483
RGD:6903857
NCBI chr15:41,957,826...42,002,776
G
AGTR2
angiotensin II receptor type 2
ISO
RGD
PMID:14982483
RGD:6903857
G
AIF1
allograft inflammatory factor 1
ISO
protein:decreased expression:brain (rat)
RGD
PMID:19070908
RGD:2313024
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:24939579
RGD:13782350
NCBI chr 7:130,589,592...130,610,845
Ensembl chr 7:130,591,166...130,610,899
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:24939579
RGD:13782350
NCBI chr10:86,888,654...86,944,159
Ensembl chr10:86,916,527...86,943,829
G
CASP9
caspase 9
treatment
ISO
RGD
PMID:24939579
RGD:13782350
NCBI chr20:116,772,819...116,798,402
Ensembl chr20:116,772,155...116,798,930
G
CCN2
cellular communication network factor 2
ISO
protein:increased expression:kidney (rat)
RGD
PMID:19080126
RGD:2314603
NCBI chr13:41,613,838...41,617,010
Ensembl chr13:41,613,798...41,617,651
G
ENG
endoglin
ISO
kidney protein:decreased expression:lung (rat)
RGD
PMID:22151990 PMID:23022174
RGD:7248771 RGD:7257525
NCBI chr12:10,274,705...10,315,715
Ensembl chr12:10,275,064...10,315,040
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ISO
protein:increased expression:white matter of spinal cord (rat) CTD Direct Evidence: therapeutic
RGD CTD
PMID:15161688 PMID:23065176
RGD:9068912
NCBI chr24:38,873,830...38,927,657
Ensembl chr24:38,873,861...38,928,288
G
HMOX1
heme oxygenase 1
treatment
ISO
RGD
PMID:22247972
RGD:10755582
NCBI chr19:18,144,466...18,157,944
Ensembl chr19:18,144,545...18,157,971
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
G
IGF2
insulin like growth factor 2
ISO
mRNA:increased expression:brain
RGD
PMID:11213353
RGD:5509971
NCBI chr 1:1,937,414...1,951,238
Ensembl chr 1:1,936,830...1,945,388
G
IL10
interleukin 10
treatment
ISO
protein:increased expression:plasma
RGD
PMID:23788042 PMID:23968122
RGD:11049496 RGD:7365012
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
G
IL18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
LCN2
lipocalin 2
ISO
mRNA,protein:increased expression:liver, heart, kidney,spleen, serum,
RGD
PMID:23331620
RGD:126790570
NCBI chr12:9,976,278...9,981,087
Ensembl chr12:9,976,614...9,980,870
G
MAPK1
mitogen-activated protein kinase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22247605
NCBI chr19:4,246,144...4,352,648
Ensembl chr19:4,246,122...4,353,325
G
MAPK3
mitogen-activated protein kinase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22247605
NCBI chr 5:26,536,471...26,545,666
Ensembl chr 5:26,536,532...26,546,461
G
NOS1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20726721
NCBI chr11:112,642,374...112,673,882
G
PCNA
proliferating cell nuclear antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21931560
NCBI chr 2:32,936,600...32,953,635
Ensembl chr 2:32,948,196...32,953,991
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
mRNA:altered expression:jejunum, duodenum, ileum (rat)
RGD
PMID:22227376
RGD:6767294
NCBI chr16:56,863,763...56,947,479
Ensembl chr16:56,880,934...56,950,999
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:intestine
RGD
PMID:17699727
RGD:2290567
NCBI chr12:17,195,403...17,218,450
Ensembl chr12:17,192,628...17,218,315
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:intestine
RGD
PMID:17699727
RGD:2290567
NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
G
SOD1
superoxide dismutase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22247605
NCBI chr 2:60,461,219...60,472,999
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11121210 PMID:20726721
NCBI chr13:87,284,537...87,297,998
Ensembl chr13:87,280,686...87,297,974
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
G
SERPINE1
serpin family E member 1
treatment
ISO
RGD
PMID:8995730
RGD:12880012
NCBI chr28:12,047,520...12,060,662
Ensembl chr28:12,047,529...12,060,202
G
ALOX5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:1886988
RGD:4890434
NCBI chr 9:41,085,257...41,145,760
Ensembl chr 9:41,085,361...41,145,331
G
ATM
ATM serine/threonine kinase
susceptibility
ISO
associated with lung cancer;DNA:SNPs:promoter:���111G>A,126713G>A (rs189037, s373759) (human)
RGD
PMID:20171797
RGD:150340755
NCBI chr 1:99,653,208...99,786,889
Ensembl chr 1:99,653,139...99,791,520
G
C3
complement C3
ISO
Protein: increased expression: plasma
RGD
PMID:20510197
RGD:5129484
NCBI chr 6:6,250,422...6,289,264
G
C4BPA
complement component 4 binding protein alpha
ISO
Protein: increased expression: plasma
RGD
PMID:20510197
RGD:5129484
NCBI chr25:22,169,355...22,254,331
G
CBLB
Cbl proto-oncogene B
susceptibility
ISO
associated with lung non-small cell carcinoma; DNA:SNP,haplotype: :rs2305035(human)
RGD
PMID:26732495
RGD:150540334
NCBI chr22:74,961,831...75,181,307
Ensembl chr22:74,961,859...75,178,548
G
CCL17
C-C motif chemokine ligand 17
ISO
mRNA, protein:increased expression:lung, alveolar macrophage
RGD
PMID:15293604
RGD:4145517
NCBI chr 5:43,343,525...43,350,096
Ensembl chr 5:43,346,329...43,348,599
G
IL13
interleukin 13
susceptibility
ISO
associated with carcinoma, non-small-cell lung; DNA:SNPs: :rs20541, rs180925 (human)
RGD
PMID:20811626
RGD:5131286
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
G
IL1A
interleukin 1 alpha
susceptibility
ISO
associated with carcinoma, non-small-cell lung: DNA:SNPs: :rs1800587,rs17561(human)
RGD
PMID:20811626
RGD:5131286
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
G
LOC103233057
C-C motif chemokine 22
ISO
mRNA, protein:increased expression:lung, alveolar macrophage
RGD
PMID:15293604
RGD:4145517
NCBI chr 5:43,297,206...43,305,662
Ensembl chr 5:43,297,897...43,305,642
G
MIF
macrophage migration inhibitory factor
susceptibility
ISO
associated with carcinoma, non-small-cell lung; DNA:SNP: :rs755622(human)
RGD
PMID:20811626
RGD:5131286
NCBI chr19:7,000,837...7,001,700
Ensembl chr19:7,000,793...7,001,757
G
NOS3
nitric oxide synthase 3
susceptibility
ISO
associated with carcinoma, non-small-cell lung;DNA:SNP:cds:c.894G>T rs1799983 (human)
RGD
PMID:20811626
RGD:5131286
NCBI chr21:119,174,829...119,196,840
G
SFTPD
surfactant protein D
susceptibility
ISO
RGD
PMID:20459699
RGD:4143486
NCBI chr 9:51,809,241...51,820,974
Ensembl chr 9:51,811,052...51,820,650
G
TGFB1
transforming growth factor beta 1
susceptibility
ISO
DNA:SNP:exon:869T>C (rs1982073) (human) protein:increased expression:blood
RGD
PMID:18411002 PMID:19380441 PMID:19943923
RGD:4145121 RGD:4145136 RGD:4145278
NCBI chr 6:35,651,583...35,674,387
Ensembl chr 6:35,648,677...35,674,365
G
TNF
tumor necrosis factor
susceptibility
ISO
associated with carcinoma, non-small-cell lung: DNA:SNPs: :rs1799724(human)
RGD
PMID:20811626
RGD:5131286
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
RGD
PMID:18347190
RGD:5131153
NCBI chr11:6,364,544...6,378,880
Ensembl chr11:6,364,330...6,378,902
G
VTN
vitronectin
ISO
Protein: increased expression: plasma
RGD
PMID:20510197
RGD:5129484
NCBI chr16:22,133,903...22,138,077
Ensembl chr16:22,133,138...22,136,815
G
CD274
CD274 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28736328
NCBI chr12:74,038,844...74,060,662
Ensembl chr12:74,041,767...74,056,806
G
CEBPA
CCAAT enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21346772
NCBI chr 6:28,342,506...28,345,759
Ensembl chr 6:28,343,907...28,344,977
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all